AAAAAA
Results: 1-25/31
Authors:
Klareskog, L
Nordmark, B
Lindblad, S
Citation: L. Klareskog et al., On the organization of an early arthritis clinic, BEST PR R C, 15(1), 2001, pp. 1-15
Authors:
Hafstrom, I
Ringertz, B
Spangberg, A
von Zweigbergk, L
Brannemark, S
Nylander, I
Ronnelid, J
Laasonen, L
Klareskog, L
Citation: I. Hafstrom et al., A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens, RHEUMATOLOG, 40(10), 2001, pp. 1175-1179
Authors:
Barton, A
Eyre, S
Myerscough, A
Brintnell, B
Ward, D
Ollier, WER
Lorentzen, JC
Klareskog, L
Silman, A
John, S
Citation: A. Barton et al., High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis, HUM MOL GEN, 10(18), 2001, pp. 1901-1906
Authors:
Hassan, AB
Gunnarsson, I
Karlsson, G
Klareskog, L
Forslid, J
Lundberg, IE
Citation: Ab. Hassan et al., Longitudinal study of interleukin-10, tumor necrosis factor-alpha, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue disease, SC J RHEUM, 30(5), 2001, pp. 282-289
Authors:
Spetea, M
Harris, HE
Berzetei-Gurske, IP
Klareskog, L
Schmidhammer, H
Citation: M. Spetea et al., Binding, pharmacological and immunological profiles of the delta-selectiveopioid receptor antagonist HS 378, LIFE SCI, 69(15), 2001, pp. 1775-1782
Authors:
Svenungsson, E
Andersson, M
Brundin, L
van Vollenhoven, R
Khademi, M
Tarkowski, A
Greitz, D
Dahlstrom, M
Lundberg, I
Klareskog, L
Olsson, T
Citation: E. Svenungsson et al., Increased levels of proinflammatory cytokines and nitric oxide metabolitesin neuropsychiatric lupus erythematosus, ANN RHEUM D, 60(4), 2001, pp. 372-379
Authors:
Berg, L
Lampa, J
Rogberg, S
van Vollenhoven, R
Klareskog, L
Citation: L. Berg et al., Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNF alpha receptors, ANN RHEUM D, 60(2), 2001, pp. 133-139
Authors:
Englund, P
Lindroos, E
Nennesmo, I
Klareskog, L
Lundberg, IE
Citation: P. Englund et al., Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies, AM J PATH, 159(4), 2001, pp. 1263-1273
Authors:
Berg, L
Ronnelid, J
Sanjeevi, CB
Lampa, J
Klareskog, L
Citation: L. Berg et al., Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB10401 and HLA-DQ8, ARTHRITIS R, 2(1), 2000, pp. 75-84
Authors:
Gunnarsson, I
Nordmark, B
Bakri, AH
Grondal, G
Larsson, P
Forslid, J
Klareskog, L
Ringertz, B
Citation: I. Gunnarsson et al., Development of lupus-related side-effects in patients with early RA duringsulphasalazine treatment - the role of IL-10 and HLA, RHEUMATOLOG, 39(8), 2000, pp. 886-893
Authors:
Lundberg, I
Antohi, S
Takeuki, K
Arnett, F
Steiner, G
Brumeanu, TD
Klareskog, L
Bona, C
Citation: I. Lundberg et al., Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome, J AUTOIMMUN, 14(3), 2000, pp. 267-274
Authors:
Magnusson, V
Lindqvist, AKB
Castillejo-Lopez, C
Kristjansdottir, H
Steinsson, K
Grondal, G
Sturfelt, G
Truedsson, L
Svenungsson, E
Lundberg, I
Gunnarsson, I
Bolstad, AI
Haga, HJ
Jonsson, R
Klareskog, L
Alcocer-Varela, J
Alarcon-Segovia, D
Terwilliger, JD
Gyllensten, UB
Alarcon-Riquelme, ME
Citation: V. Magnusson et al., Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus, GENOMICS, 70(3), 2000, pp. 307-314
Authors:
Grondal, G
Gunnarsson, I
Ronnelid, J
Rogberg, S
Klareskog, L
Lundberg, I
Citation: G. Grondal et al., Cytokine production, serum levels and disease activity in systemic lupus erythematosus, CLIN EXP RH, 18(5), 2000, pp. 565-570
Authors:
Blomqvist, P
Feltelius, N
Ekbom, A
Klareskog, L
Citation: P. Blomqvist et al., Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions, J RHEUMATOL, 27(5), 2000, pp. 1171-1177
Authors:
Hansson, T
Dahlbom, I
Hall, J
Holtz, A
Elfman, L
Dannaeus, A
Klareskog, L
Citation: T. Hansson et al., Antibody reactivity against human and guinea pig tissue transglutaminase in children with celiac disease, J PED GASTR, 30(4), 2000, pp. 379-384
Authors:
Mattsson, L
Larsson, P
Erlandsson-Harris, H
Klareskog, L
Harris, RA
Citation: L. Mattsson et al., Parasite-mediated down-regulation of collagen-induced arthritis (CIA) in DA rats, CLIN EXP IM, 122(3), 2000, pp. 477-483
Authors:
Berg, L
Ronnelid, J
Klareskog, L
Bucht, A
Citation: L. Berg et al., Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness, CLIN EXP IM, 120(1), 2000, pp. 174-182
Authors:
Ulfgren, AK
Andersson, U
Engstrom, M
Klareskog, L
Maini, RN
Taylor, PC
Citation: Ak. Ulfgren et al., Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis, ARTH RHEUM, 43(11), 2000, pp. 2391-2396
Authors:
Smolen, JS
Breedveld, FC
Burmester, GR
Combe, B
Emery, P
Kalden, JR
Klareskog, L
Maini, RN
Numo, R
van de Putte, LBA
van Riel, PLCM
Rodriguez-Valverde, V
Citation: Js. Smolen et al., Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis, ANN RHEUM D, 59(7), 2000, pp. 504-505
Authors:
Bresnihan, B
Tak, PP
Emery, P
Klareskog, L
Breedveld, F
Citation: B. Bresnihan et al., Synovial biopsy in arthritis research: five years of concerted European collaboration, ANN RHEUM D, 59(7), 2000, pp. 506-510
Authors:
Silman, A
Klareskog, L
Breedveld, F
Bresnihan, B
Maini, R
van Riel, P
Symmons, D
Citation: A. Silman et al., Proposal to establish a register for the long term surveillance of adverseevents in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds, ANN RHEUM D, 59(6), 2000, pp. 419-420
Authors:
Ulfgren, AK
Grondal, L
Lindblad, S
Khademi, M
Johnell, O
Klareskog, L
Andersson, U
Citation: Ak. Ulfgren et al., Interindividual and intra-articular variation of proinflammatory cytokinesin patients with rheumatoid arthritis: potential implications for treatment, ANN RHEUM D, 59(6), 2000, pp. 439-447
Authors:
Ulfgren, AK
Klareskog, L
Lindberg, M
Citation: Ak. Ulfgren et al., An immunohistochemical analysis of cytokine expression in allergic and irritant contact dermatitis, ACT DER-VEN, 80(3), 2000, pp. 167-170
Authors:
Klareskog, L
McDevitt, H
Citation: L. Klareskog et H. Mcdevitt, Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune reactions, CURR OP IM, 11(6), 1999, pp. 657-662
Authors:
Johanneson, N
Steinsson, K
Lindqvist, AK
Kristjansdottir, H
Grondal, G
Sandino, S
Tjernstrom, F
Sturfelt, G
Granados-Arriola, J
Alcocer-Varela, J
Lundberg, I
Jonasson, I
Truedsson, L
Svenungssons, E
Klareskog, L
Alarcon-Segovia, D
Gyllensten, UB
Alarcon-Riquelme, ME
Citation: N. Johanneson et al., A comparison of genome-scans performed in multicase families with systemiclupus erythematosus from different population groups, J AUTOIMMUN, 13(1), 1999, pp. 137-141